ESSEX BIO-TECH 01061Hong Kong Stock Exchange

2.1503.12%( +0.065 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
ESSEX BIO-TECH (01061) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2011-06-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG312371035

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.64B42/112
Net Profit (Last FY)287.31M37/125
ROE (Last FY)13.18%17/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
严名炽 Executive Director
方海洲 Executive Director
严贤龙 Executive Director
邱丽文 Executive Director
冯志英 Independent Non-Executive Director
邱梅美 Independent Non-Executive Director
甄文星 Independent Non-Executive Director
会」) Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2023-06-09.

About this page

This page shows ESSEX BIO-TECH (01061) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.